Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia

References

• WunderinkRGWatererGWClinical practice. Community-acquired pneumoniaN Engl J Med2014370654355124499212
   PubMed Web of Science ®Google Scholar
• CampbellSGMarrieTJAnsteyRAckroyd-StolarzSDickinsonGUtility of blood cultures in the management of adults with community acquired pneumonia discharged from the emergency departmentEmerg Med J200320652152314623837
   PubMed Web of Science ®Google Scholar
• MarrieTJBlood cultures in ambulatory patients who are discharged from emergency with community-acquired pneumoniaCan J Infect Dis2004151212418159439
   PubMedGoogle Scholar
• MeterskyMLMaABratzlerDWHouckPMPredicting bacteremia in patients with community-acquired pneumoniaAm J Respir Crit Care Med2004169334234714630621
   PubMed Web of Science ®Google Scholar
• BordonJPeyraniPBrockGNThe presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort studyChest2008133361862418198264
   PubMed Web of Science ®Google Scholar
• DellingerRPLevyMMRhodesASurviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012Intensive Care Med201339216522823361625
   PubMed Web of Science ®Google Scholar
• NiedermanMSUse of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organismsClin Infect Dis200642Suppl 2S72S8116355320
   PubMed Web of Science ®Google Scholar
• NiedermanMSDe-escalation therapy in ventilator-associated pneumoniaCurr Opin Crit Care200612545245716943725
   PubMed Web of Science ®Google Scholar
• NiedermanMSThe importance of de-escalating antimicrobial therapy in patients with ventilator-associated pneumoniaSemin Respir Crit Care Med2006271455016508881
   PubMed Web of Science ®Google Scholar
• SchlueterMJamesCDominguezATsuLSeymannGPractice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumoniaInfection201038535736220652354
   PubMed Web of Science ®Google Scholar
• KimJWChungJChoiSHEarly use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trialCrit Care2012161R2822336530
   PubMed Web of Science ®Google Scholar
• NiedermanMSSoulountsiVDe-escalation therapy: is it valuable for the management of ventilator-associated pneumonia?Clin Chest Med201132351753421867820
   PubMed Web of Science ®Google Scholar
• DucheneEMontassierEBoutoilleDCaillonJPotelGBatardEWhy is antimicrobial de-escalation under-prescribed for urinary tract infections?Infection201341121121423124907
   PubMed Web of Science ®Google Scholar
• ShimeNSatakeSFujitaNDe-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patientsInfection201139431932521509424
   PubMed Web of Science ®Google Scholar
• DonaldsonADBarkhamTDe-escalation for amoxicillin-susceptible Escherichia coli: easier said than doneJ Hosp Infect201074330430519782431
   PubMed Web of Science ®Google Scholar
• EachempatiSRHydoLJShouJBariePSDoes de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?J Trauma20096651343134819430237
   PubMedGoogle Scholar
• LinMYLyles-BanksRDLolansKThe importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing EnterobacteriaceaeClin Infect Dis20135791246125223946222
   PubMed Web of Science ®Google Scholar
• ChoiJPChoEHLeeSJLeeSTKooMSSongYGInflux of multidrug resistant, Gram-negative bacteria (MDRGNB) in a public hospital among elderly patients from long-term care facilities: a single-center pilot studyArch Gerontol Geriatr2012542e19e2221764147
   PubMed Web of Science ®Google Scholar
• RiegSPeyerl-HoffmannGde WithKMortality of S. aureus bacteremia and infectious diseases specialist consultation – a study of 521 patients in GermanyJ Infect200959423223919654021
   PubMed Web of Science ®Google Scholar
• HondaHKraussMJJonesJCOlsenMAWarrenDKThe value of infectious diseases consultation in Staphylococcus aureus bacteremiaAm J Med2010123763163720493464
   PubMed Web of Science ®Google Scholar
• PaulMBenuri-SilbigerISoares-WeiserKLeiboviciLBeta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trialsBMJ2004328744166814996699
   PubMed Web of Science ®Google Scholar
• BliziotisIASamonisGVardakasKZChrysanthopoulouSFalagasMEEffect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the Zemergence of antimicrobial resistance: a meta-analysis of randomized, controlled trialsClin Infect Dis200541214915815983909
   PubMed Web of Science ®Google Scholar
• DeanNCSilverMPBatemanKAJamesBHadlockCJHaleDDecreased mortality after implementation of a treatment guideline for community-acquired pneumoniaAm J Med2001110645145711331056
   PubMed Web of Science ®Google Scholar
• MeterskyMLMaAHouckPMBratzlerDWAntibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolonesChest2007131246647317296649
   PubMed Web of Science ®Google Scholar
• Garnacho-MonteroJSa-BorgesMSole-ViolanJOptimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapyCrit Care Med20073581888189517581492
   PubMed Web of Science ®Google Scholar
• ChamotEBoffi El AmariERohnerPVan DeldenCEffectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremiaAntimicrob Agents Chemother20034792756276412936970
   PubMed Web of Science ®Google Scholar